Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiji Ueda

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2005
Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and boneShinichiro Kume, Seiya Kato, Sho-ichi Yamagishi, et al.
Microvascular Research|June 15, 2007
Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expressionSho-ichi Yamagishi, Takanori Matsui, Kazuo Nakamura, et al.
Clinical Immunology (Orlando, Fla.)|December 17, 2013
Protective role of JAK/STAT signaling against renal fibrosis in mice with unilateral ureteral obstructionKiyomi Koike, Seiji Ueda, Sho-ichi Yamagishi, et al.
Microvascular Research|May 8, 2013
Telmisartan inhibits AGE-induced podocyte damage and detachmentKei Fukami, Sho-ichi Yamagishi, Kumiko Kaifu, et al.
Microvascular Research|August 14, 2016
Corrigendum to "Telmisartan inhibits AGE-induced podocyte damage and detachment" [Microvascular Research 88 (2013) 79-83]Kei Fukami, Sho-Ichi Yamagishi, Kumiko Kaifu, et al.
Journal of Clinical Laboratory Analysis|September 25, 2014
Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non-B or Non-C Hepatocellular CarcinomaHiromi Kan, Sho-ichi Yamagishi, Ayako Ojima, et al.
Life Sciences|April 9, 2009
Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD)Seiji Ueda, Sho-ichi Yamagishi, Yuriko Matsumoto, et al.
Journal of Atherosclerosis and Thrombosis|October 21, 2003
Overexpression of p21Waf1 induces apoptosis in immortalized human vascular smooth muscle cellsSeiya Kato, Seiji Ueda, Miki Yamaguchi, et al.
Metabolism: Clinical and Experimental|March 6, 2012
Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) levelYuji Ishibashi, Sho-ichi Yamagishi, Takanori Matsui, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 19, 2024
Effect of fruits granola (Frugra®) consumption on blood pressure reduction and intestinal microbiome in patients undergoing hemodialysisHajime Nagasawa, Shogo Suzuki, Takashi Kobayashi, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2005
Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and boneShinichiro Kume, Seiya Kato, Sho-ichi Yamagishi, et al.
Microvascular Research|June 15, 2007
Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expressionSho-ichi Yamagishi, Takanori Matsui, Kazuo Nakamura, et al.
Clinical Immunology (Orlando, Fla.)|December 17, 2013
Protective role of JAK/STAT signaling against renal fibrosis in mice with unilateral ureteral obstructionKiyomi Koike, Seiji Ueda, Sho-ichi Yamagishi, et al.
Microvascular Research|May 8, 2013
Telmisartan inhibits AGE-induced podocyte damage and detachmentKei Fukami, Sho-ichi Yamagishi, Kumiko Kaifu, et al.
Microvascular Research|August 14, 2016
Corrigendum to "Telmisartan inhibits AGE-induced podocyte damage and detachment" [Microvascular Research 88 (2013) 79-83]Kei Fukami, Sho-Ichi Yamagishi, Kumiko Kaifu, et al.
Journal of Clinical Laboratory Analysis|September 25, 2014
Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non-B or Non-C Hepatocellular CarcinomaHiromi Kan, Sho-ichi Yamagishi, Ayako Ojima, et al.
Life Sciences|April 9, 2009
Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD)Seiji Ueda, Sho-ichi Yamagishi, Yuriko Matsumoto, et al.
Journal of Atherosclerosis and Thrombosis|October 21, 2003
Overexpression of p21Waf1 induces apoptosis in immortalized human vascular smooth muscle cellsSeiya Kato, Seiji Ueda, Miki Yamaguchi, et al.
Metabolism: Clinical and Experimental|March 6, 2012
Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) levelYuji Ishibashi, Sho-ichi Yamagishi, Takanori Matsui, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 19, 2024
Effect of fruits granola (Frugra®) consumption on blood pressure reduction and intestinal microbiome in patients undergoing hemodialysisHajime Nagasawa, Shogo Suzuki, Takashi Kobayashi, et al.
Pageof 13